Neovascular glaucoma

DM_NEOVASCULAR_GLAUCOMA

neovascular glaucoma: Neovascular glaucoma is the most common type of secondary glaucoma, usually caused by diabetic retinopathy, central retinal vein occlusion and carotid artery obstruction but sometimes by trauma, uvietis or ocular tumors, and characterized by severe eye pain, synechial angle glaucoma, high intraocular pressure and leading to loss of vision.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 H40.5
Cause of death: ICD-10 H40.5

2 out of 7 registries used, show all original rules.

1151

diagram downward connector

Check minimum number of events None

1151

diagram downward connector

Include endpoints None

1151

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

1100

diagram downward connector
DM_NEOVASCULAR_GLAUCOMA

Control definitions

Control exclude DM_RETINOPATHY

Extra metadata

First used in FinnGen datafreeze DF2
Parent code in ICD-10 H40
Name in latin Glaucoma [secundarium] post aliam morbositatem oculi

Summary Statistics

Key figures

All Female Male
Number of individuals 1100 510 590
Unadjusted prevalence (%) 0.29 0.24 0.35
Mean age at first event (years) 60.36 56.94 63.31

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 4.00 [2.45, 6.53] 2.9e-8 239
15 years 0.01 1.91 [1.31, 2.79] 7.8e-4 96
5 years 0.01 4.34 [3.27, 5.75] 3.0e-24 102
1 year 0.00 4.63 [2.86, 7.48] 3.9e-10 26

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: DM_NEOVASCULAR_GLAUCOMA – Neovascular glaucoma
GWS hits: 1

Survival analyses between endpoints

Plot

before Neovascular glaucoma
after Neovascular glaucoma

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Neovascular glaucoma

Endpoint not on priority list, no data to show.